ormation provided by Psychemedics may contain forward-looking
information that involves risks and uncertainties. In particular,
statements contained in this release that are not historical facts
(including but not limited to statements concerning earnings, earnings per
share, revenues, dividends, future business, growth opportunities, new
accounts, customer base, market share, test volume and sales and marketing
strategies) may be "forward looking" statements. Actual results may differ
from those stated in any forward-looking statements. Factors that may cause
such differences include but are not limited to risks associated with the
expansion of the Company's sales and marketing team, development of markets
for new products and services offered, the economic health of principal
customers of the Company, government regulation, including but not limited
to FDA regulations, competition and general economic conditions and other
factors disclosed in the Company's filings with the Securities and Exchange
Commission.
Contact: Jennifer Chmieleski
Vice President and Controller
(978) 206-8220
Jenniferc@psychemedics.com
PSYCHEMEDICS CORPORATION
STATEMENTS OF INCOME
(in thousands, except per share amounts)
UNAUDITED
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 2008 2007
Revenue $6,211 $6,497 $11,920 $12,214
Cost of revenue 2,435 2,387 4,822 4,842
Gross profit 3,776 4,110 7,098 7,372
Expenses:
General and administrative 1,095 1,029
'/>"/>
SOURCE Psychemedics Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Psychemedics Corporation Announces First Quarter Results2.
Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue3.
Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer4.
Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book5.
HealthFitness Corporation to Report Second Quarter Financial Results6.
Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options7.
Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months8.
minSURG(TM) Corporation Launches International Division9.
Baxa Corporation Launches New Electronic Users Group Web Site10.
Leatt Corporation To Sponsor 2008 South African Motocross Grand Prix11.
China Medicine Corporation Obtains Australian Patent for rADTZ